Open AccessPrognostic Implications of Creatine Kinase-MB Elevation After Percutaneous Coronary Intervention
Author(s) -
Jason B. Lindsey,
Kevin F. Kennedy,
Joshua M. Stolker,
Ian C. Gilchrist,
Debabrata Mukherjee,
Steven P. Marso,
Michael Pencina,
Neal S. Kleiman,
David J. Cohen
Publication year - 2011
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7640
pISSN - 1941-7632
DOI - 10.1161/circinterventions.111.962233
Subject(s) - percutaneous coronary intervention , medicine , creatine kinase , cardiology , elevation (ballistics) , myocardial infarction , engineering , structural engineering
Creatine kinase-MB (CK-MB) elevation after percutaneous coronary intervention (PCI) has been associated with increased risk for mortality. Although most studies have defined periprocedural myocardial infarction (pMI) as an elevation in CK-MB >3× upper limit of normal (ULN), use of different CK-MB assays and variation in site-specific definitions of the ULN may limit the value of such relative thresholds.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom